the role of brca and parp in dna repair and brca-related breast cancer
Published 9 years ago • 975 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
8:37
brca1 and brca2 mutations & cancer (types of cancer, and who’s most at risk)
-
5:03
the mechanisms of brca-related breast cancer and molecular profiling
-
2:07
parp inhibitors and the embraca study of talazoparib in brca-related metastatic breast cancer
-
1:52
parpi for somatic brca1/2 and other dna repair gene mutations in women with metastatic breast cancer
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
3:45
current research into treatments for brca-related breast cancer and the phase 3 embraca trial
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
1:22
role of brca mutations in bc
-
3:58
brca breast cancer: the advent of parp inhibitors
-
6:19
chemosymposium 2011: parp treatment for brca mutated and triple negative breast cancer
-
3:52
understanding brca mutations and risk
-
4:59
future role of parp inhibition in brca breast cancer
-
4:19
treating brca breast cancer with parp inhibition
-
4:09
doctor explains brca1 & brca2 genetic testing for inherited breast and ovarian cancer...
-
5:19
parp inhibitors for brca-associated tnbc
-
7:57
brca testing in ovarian cancer
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
2:19
phase iii results of olaparib for brca breast cancer
-
0:54
parp inhibitors advance beyond treatment of brca1/2-mutant gynecologic cancers